Lilly Fluoxetine For Premenstrual Dysphoria Merits Separate Indication
Executive Summary
Labeling for Lilly's fluoxetine (Prozac) should include a separate indication for premenstrual dysphoric disorder, FDA's Psychopharmacologic Drugs Advisory Committee agreed Nov. 3.
You may also be interested in...
Prozac For Premenstrual Dysphoric Disorder May Get "Fem"-inine Touch
Lilly is planning to market its blockbuster antidepressant Prozac (fluoxetine) with separate packaging and a new name for treatment of premenstrual dysphoric disorder.
Is It PMS Or PMDD?
Markedly depressed mood Feelings of hopelessness Marked anxiety Marked lability Persistant anger Decreased interest in usual activities Subjective sense of difficulty in concentrating Lethargy, easy fatigability, or lack of energy Hypersomnia or insomnia Subjective sense of being overwhelmed or out of control Other physical symptoms
Prozac For Premenstrual Dysphoric Disorder May Get "Fem"-inine Touch
Lilly is planning to market its blockbuster antidepressant Prozac (fluoxetine) with separate packaging and a new name for treatment of premenstrual dysphoric disorder.